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A B S T R A C T
Spot urinary concentrations of environmental exposure biomarkers require correction for dilution. There is no
consensus on the most appropriate method, with creatinine used by default despite lacking theoretical robust-
ness. We comparatively assessed the efficacy of creatinine; specific gravity (SG); osmolality and modifications of
all three for dilution correcting urinary arsenic. For 202 participants with urinary arsenic, creatinine, osmolality
and SG measurements paired to drinking water As, we compared the performance corrections against two in-
dependent criteria: primarily, (A) correlations of corrected urinary As and the dilution measurements used to
correct them - weak correlations indicating good performance and (B) correlations of corrected urinary As and
drinking water As - strong correlations indicating good performance. More than a third of variation in spot
urinary As concentrations was attributable to dilution. Conventional SG and osmolality correction removed
significant dilution variation from As concentrations, whereas conventional creatinine over-corrected, and
modifications of all three removed measurable dilution variation. Modified creatinine and both methods of SG
and osmolality generated stronger correlations of urinary and drinking water As concentrations than conven-
tional creatinine, which gave weaker correlations than uncorrected values. A disparity in optima between
performance criteria was observed, with much smaller improvements possible for Criterion B relative to A.
Conventional corrections – particularly creatinine - limit the utility spot urine samples, whereas a modified
technique outlined here may allow substantial improvement and can be readily retrospectively applied to ex-
isting datasets. More studies are needed to optimize urinary dilution correction methods. Covariates of urinary
dilution measurements still warrant consideration.
1. Introduction
Urinary biomonitoring is a widely used tool for environmental ex-
posure assessment, the evaluation of suspected carcinogens and toxins,
exposomics and metabolomics, nutritional science and numerous other
applications. Despite its longstanding employment, the non-invasive-
ness, logistical and analytical appeal of urinary biomonitoring are yet to
be matched by robust data processing and interpretation protocols
(Sobus et al., 2015; Barrett, 2015). Urinary analyte concentrations are
subject to variation from several factors (Aylward et al., 2014): (i)
sample collection timing relative to exposure; (ii) inter/intra-individual
toxicokinetics and (iii) physicochemical characteristics of the urinary
matrix. We address the third factor, namely the inter-individual hy-
dration-driven dilution variation in spot urine samples, in the present
paper. Failure to properly account for this and other sources of varia-
tion in urinary analyte concentrations is currently limiting the potential
of a convenient and growing resource of invaluable biomonitoring data
for environmental research and other epidemiological investigations
(Middleton et al., 2016a).
When comparing urinary biomonitoring results between different
individuals within a population, it is necessary to account for inter-
individual differences in sample dilution so that ‘like with like’ com-
parisons can be made and robust relationships between biomarker
concentrations and external exposure metrics and/or health endpoints
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can be explored. Several approaches exist for correcting urinary analyte
concentrations for dilution variation, the most common of which are
creatinine - whereby analyte concentrations are expressed as ratios
against creatinine concentrations (Eq. (1)); specific gravity (SG) (Eq.
(2)) (Levine, 1945) and osmolality correction (replacing SG-1 for ur-
inary osmolality in Eq. (2)).=C C C/ ,cor vol cr (1)
where Ccor is dilution corrected analyte concentration (in the above
case expressed as the ratio μg/g creatinine), Cvol is the measured, vo-
lume based analyte concentration (typically in μg/L) and Ccr is creati-
nine concentration in g/L.= ×C C SG SG(( 1)/( 1)),cor vol ref meas (2)
where SGref is the reference value (e.g. often the median study group
SG) to which analyte concentrations are normalised and SGmeas is that
measured in a given specimen. We note that Eq. (1) is equivalent to
substituting creatinine for SG-1 in Eq. (2) and normalizing to a creati-
nine concentration of 1 g/L.
These corrections utilise measurements that act as proxies for ur-
inary flow rate (UFR) – the volume of urine produced in a given
timeframe and the ultimate property of interest (Middleton et al.,
2016a; Hays et al., 2015; Araki et al., 1990), albeit cumbersome to
quantify. Creatinine correction assumes that creatinine – a breakdown
product of muscle creatine phosphate - is excreted at a constant rate and
varies only by UFR. This has been repeatedly disputed, with creatinine
concentrations having been shown to vary by demographic group (Barr
et al., 2005), protein intake (Mayersohn et al., 1983) and muscle mass
(Baxmann et al., 2008). Osmolality, regarded as the definitive measure
of urinary concentration (Leech and Penney, 1987), accounts for the
entire solute content of the sample. Specific gravity is an estimate of
osmolality conveniently measured by refractometry and, while close
agreement has been demonstrated between the two measurements
(Barber and Wallis, 1986), overestimations of SG relative to osmolality
can occur in the presence of high molecular weight solutes (e.g. samples
from subjects with albuminuria) (Leech and Penney, 1987). Osmolality
too has been shown to vary by demographic and physical attributes,
albeit less so than creatinine concentrations (Yeh et al., 2015).
Comparatively less attention has been paid to the mathematical
modification of dilution corrections, which assume that both the ana-
lyte under investigation and dilution measurement change pro-
portionally in response to UFR if performed in their conventional
manner (Eqs. (1) and (2)). This assumption was shown to be invalid
almost 30 years ago by Araki et al. (1990), who reported analyte-spe-
cific, log-linear relationships between analyte concentrations and UFR
derived from single individuals across various hydration states:=log C a b log UFR,vol (3)
where a and b are analyte-dependent, empirically determined regres-
sion coefficients. This finding may have particularly profound im-
plications for creatinine correction, which is susceptible to the specific
excretion kinetics of creatinine as opposed to osmolality and SG which
reflect total solute content, unless correcting concentrations of an
analyte with a slope (b) close to that of creatinine. It is, however,
possible to account for these excretion differences in correction equa-
tions (Araki et al., 1990). We therefore propose for consideration a pre-
existing modification of all three commonly used adjustment methods
based on previous expansions of Araki's work (Vij and Howell, 1998a;
Middleton et al., 2016b) as follows:
= ×C C D D( / ) ,cor vol ref meas z (4)
where D is the dilution measurement being used (cf. Eq. (2); minus
unity in the case of SG) and z, in theory, is empirically derived by di-
viding the regression slope of As (bAs) against UFR by that of the di-
lution metric (bD) against UFR, hence z= bAs/bD.
As already noted, Dref for creatinine is routinely= 1 g/L, therefore
the modified equation can also be expressed as follows (cf. Eq. (1)):
=C C C/ ,cor vol cr z (5)
Despite evidence of its inefficacy (Middleton et al., 2016a; Nermell
et al., 2008a), conventional creatinine correction remains a routine and
often default approach to adjusting urinary analytes, as demonstrated
by a Google Scholar search using the term “urine; (one of creatinine,
specific gravity, osmolality) correction OR adjustment”, which returned
1980, 234 and 61 results, respectively and an almost identical pro-
portional distribution when arsenic was added to the term. More studies
are beginning to consider alternatives (Athanasiadou et al., 2018; Bulka
et al., 2017), but there is a paucity of investigations using objective
criteria to comparatively assess different approaches. We previously
proposed four criteria for assessing the performance of dilution cor-
rection methods (Table 1). This set of criteria is by no means exhaustive
and the suitability of each criterion may be study-specific; nevertheless
it provides a good starting point for investigation.
In the present study, we aim to comparatively assess the perfor-
mance of conventional creatinine, SG, osmolality and a modified ap-
plication of all three methods in dilution correcting concentrations of
urinary arsenic (As) in a population of UK participants exposed to
various levels of As from private drinking water supplies. As the re-
moval of hydration-driven dilution variation is the intended result of
correction methods, we primarily assess performance in relation to
Criterion A in Table 1, but also assess how adjustments affect the cor-
relation between urinary and drinking water As concentrations (Cri-
terion B in Table 1). Inorganic As is an established carcinogen (IARC,
2012) of the lung, bladder and skin and is associated with numerous
other non-communicable diseases, including cardiovascular disease
(Navas-Acien et al., 2005) and diabetes mellitus (Navas-Acien et al.,
2008), for which urinary biomonitoring is the preferred measure of
exposure assessment (Orloff et al., 2009). To our knowledge, this is the
first investigation to assess the performance of these correction methods
on a study population with paired urine and drinking water samples,
thus allowing assessment against two independent criteria.
Table 1
Suggested criteria for assessing performance of urinary biomonitoring dilution correction methods (Middleton et al., 2016a, b, c, d). The criteria employed in the
present study are labelled A and B.
Criterion Description Performance metric
A Correlation between corrected spot analyte concentrations and UFR (by proxy in the
present paper).
Weaker correlations indicating good performance.
Not used in the present
study
Correlation between corrected spot analyte concentrations and an independent measure
of internal dose, e.g. analyte concentrations in blood.
Stronger correlations indicating good performance.
Not used in the present
study
Correlation of spot analyte concentrations with analyte excretion over 24 h or composite
24 h concentrations.
Closer agreement/lower variation in spot samples
indicating good performance.
B Correlation of spot analyte concentrations with an independent measure of/proxy for
external exposure e.g. drinking water analyte concentrations.
Stronger correlations indicating good performance.
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2. Materials and methods
2.1. Ethical approval
Ethical approval for the study was granted by the University of
Manchester Research Ethics Committee (Ref 13068) and the NHS
Health Research Authority National Research Ethics Committee (NRES)
(Ref 13/EE/0234). In accordance with approved guidelines, written
informed consent was obtained from all participants.
2.2. Participant recruitment and sample collection
Paired urine and drinking water samples were collected from par-
ticipants' homes in Cornwall, south west England between November
and December 2013 as part of an investigation into As exposure from
various environmental sources (Middleton et al., 2016c; Middleton
et al., 2016d; Middleton et al., 2017; Middleton et al., 2018). Point-of-
use drinking water samples were collected from the tap most frequently
used for consumption in LDPE containers (Nalgene, USA). Spot (85%
first morning void), mid-stream urine samples collected and re-
frigerated by participants in 60mL HDPE containers (Nalgene, USA)
and stored in a cool box during transit. An electronic questionnaire was
administered to obtain age and gender.
2.3. Chemical analysis
On arrival at the laboratory, SG was measured using a temperature-
corrected, handheld PAL-10-S digital refractometer (Atago, Japan)
prior to samples being filtered through 0.45 μm Acrodisc® syringe filters
(PALL Life Sciences, USA) into 30mL HDPE containers (Nalgene, USA)
and frozen at −30 °C. Samples were thawed at room temperature be-
fore subsequent analyses were conducted. Creatinine concentrations
were determined by the colorimetric Jaffe method (Jaffe, 1886) using a
Randox liquid assay kit and a Randox RX Imola chemistry analyser.
Osmolality was measured by cryoscopic (freezing point) osmometry
using a Gonotect Osmomat 030 instrument (Gonetec, Germany). Total
As in drinking water and urinary arsenic speciation were determined
using previously detailed methodologies and QC procedures (Middleton
et al., 2016d). In brief, inductively coupled plasma mass spectrometry
(ICP-MS) (Agilent 7500 Series, Agilent Technologies, USA) was used to
analyse drinking water samples and urinary arsenic speciation was
performed with high performance liquid chromatography coupled to
ICP-MS (HPLC-ICP-MS). Urinary inorganic As and methylated meta-
bolites (AsIMM) was calculated as the sum of inorganic As(III), inorganic
As (V), methylarsonate (MA) and dimethylarsinate (DMA) species. This
is the routine biomarker of As exposure; does not incorporate non-toxic
arsenobetaine and is therefore more reflective of exposure to inorganic
arsenic from drinking water.
2.4. Quality control
Accuracy was assessed using certified reference materials (CRM),
which were analysed simultaneously with drinking water and urine
samples: NIST SRM 1643e Trace Elements in Water (National Institute
of Standards and Technology, USA) (certified value: 58.98 ± 0.70As
μg/L, recovery: 100% (n=4), precision: 3%) and NIES No.18 Human
Urine (National Institute for Environmental Studies, Japan) (total As
certified value: 137 ± 11 μg/L, recovery: 99% (n=14), precision: 5%;
AB certified value: 69 ± 12 μg/L, recovery: 92% (n=18), precision:
5%; DMA certified value: 36 ± 9 μg/L, recovery: 115% (n=18),
precision: 12%). The accuracy of creatinine concentrations in urine was
assessed with two different quality control samples which were ana-
lysed with each batch - Randox Acusera Assayed Urine Quality Control
Level 2 (99% mean recovery, n=4) and Level 3 (102% mean recovery,
n=4). (Background contamination was monitored using procedural
blanks for urine and drinking water analyses, reagent (0.5% nitric acid)
blanks for drinking water analysis and filter blanks for urine analysis.
Precision was assessed by performing duplicate analyses. Duplicate
measurements were made on 12% (n=25) of urine samples for os-
molality (1% mean percentage difference). To assess signal stability and
the possibility of drift resulting from high urinary matrices, intra-batch
duplicates were analysed for urinary speciation (mean percentage dif-
ferences for detected species: AB: 2% (n=5), MA: 2% (n=1), DMA:
5% (n=6)).
2.5. Urinary dilution corrections
Conventional creatinine and SG correction were performed as al-
ready described using Eq. (1) and Eq. (2), respectively and conventional
osmolality correction was performed using Eq. (6).= ×C C Osm Osm( / )cor vol ref meas (6)
Values of 521mOsm/kg and 1.016 were used for Osmref and SGref –
the study group median osmolality and SG, respectively.
2.6. Correction performance assessment criteria
Dilution correction methods were assessed, primarily, against the
aforementioned criterion (Table 1):
Criterion A: Correlations between corrected spot analyte concentrations
and UFR - for the present paper, correlations between corrected AsIMM
concentrations and the dilution measurement (creatinine, SG or os-
molality) used to correct them were calculated. For the correction
method to give the desired effect, no correlation should remain post-
correction.
Performance in relation to the following independent criterion
(Table 1) was additionally assessed:
Criterion B: Correlation of spot analyte concentrations with an in-
dependent measure of/proxy for external exposure e.g. drinking water
analyte concentrations – for the present paper, correlations between
drinking water total As and urinary AsIMM were calculated, with
stronger correlations assumed to indicate better correction perfor-
mance.
2.7. Modified dilution corrections
Modified dilution corrections were performed as per Eq. (4) (SG/
osmolality) and Eq. (5) (creatinine). The z coefficient used in both
equations was derived (Fig. 1) using a previous numerical approach
(z= bAs / bD) (Vij and Howell, 1998b). Given that no published values
for z were available, values between 0 and 1.5 at increments of 0.01
were imputed in a loop of correlation calculations between urinary
AsIMM and the dilution measurement under modification (Criterion A).
The z value yielding the optimal correlation (R=0) was selected, re-
sulting in z values of 0.80, 1.23 and 1.2 for creatinine, SG and osmol-
ality, respectively. The limitations of this approach are addressed in the
discussion.
2.8. Statistical analysis
Statistical analysis and graphics were generated using R version
3.4.3 (base package) and the RStudio GUI. Urinary analyte data were
positively skewed, so geometric means (GM) were calculated. For this
reason, Pearson correlations of urinary AsIMM concentrations against
creatinine, SG, osmolality and drinking water As concentrations were
calculated on natural log (ln) transformed data with significance tests
(p-values) and 95% confidence intervals (CI). Linear regression models
for trend lines were also performed on ln-transformed variables. To test
the significance of the difference between correlations of, for example,
drinking water total As and urinary AsIMM yielded by different correc-
tion methods, the Williams's test was performed using the psych
package (these correlations are not independent from one another if
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they share a common variable - drinking water total As).
3. Results
3.1. Participant characteristics
Urinary AsIMM, in addition to creatinine, osmolality and SG were
measured in 202 urine samples, each of which had a paired con-
centration of total As in household drinking water. The mean age of
participants, all of whom were of white European ethnicity, was 62,
Demographic characteristics and urinary analyte summary statistics of
the study group are shown in Table 2. Detailed urinary As speciation
results and drinking water total As concentrations (GM: 1.0 μg/L; range:
0.01–233 μg/L) for this study group have been reported elsewhere
(Middleton et al., 2016d).
3.2. Effects of hydration corrections on urinary arsenic
Table 3 shows the effect of dilution corrections on urinary AsIMM
concentrations – both statistical distributions and at an individual level.
All correction methods reduced the geometric standard deviation
among concentrations but, with the exception of both osmolality cor-
rections, increased the range of concentrations. Relative to uncorrected
concentrations, large differences in AsIMM concentrations for single in-
dividuals were observed between correction methods. In particular,
conventional creatinine correction resulted in notably large differences
(GM: 39%; max: 524%) relative to uncorrected concentrations. This
was not the case for modified creatinine correction, which resulted in
differences comparable to both osmolality and SG correction.
3.3. Correction performance comparisons (Criterion A)
The performance of the different correction methods relative to both
assessment criteria are shown by the Pearson correlations in Table 4.
Performances relative to Criterion A are depicted by the scatter plots in
Fig. 2. Firstly, correlations of uncorrected urinary AsIMM against each of
osmolality (R=0.58), SG (R=0.59) and creatinine (R=0.58)
(Fig. 2A–C) demonstrate the substantial amount of dilution driven
variation in AsIMM concentrations – greater than one third of variation
was explained by dilution alone. Conventional correction methods
(Fig. 2E and F), with the exception of conventional creatinine (Fig. 2D),
removed dilution-derived variation from AsIMM concentrations and left
no statistically significant correlations between AsIMM concentrations
and dilution measurements. Conventional creatinine correction resulted
in a statistically significant over-correction (R=−0.17; 95% CI:
−0.30, −0.04) and, while not significant, SG (R=0.14; 95% CI:
−0.001, 0.27) and osmolality (R=0.12; 95% CI: −0.02, 0.25) did
yield slight under-corrections. Modified corrections, by nature, left
near-zero correlations as they were numerically optimized to do so.
This is represented graphically in Fig. 1 and demonstrates the potential
for improvement of all three methods for this Criterion, especially
creatinine correction. In summary, when assessed against Criterion A,
the following performance ranking was observed (see Table 4 for sig-
nificance of differences between non-neighbouring correction
methods): ==> >>
Creatinine (modified) SG (modified)
Osmolality (modified)
Osmolality (conventional)
SG (conventional) Creatinine (conventional)
Uncorrected
3.4. Correction performance comparisons (Criterion B)
Correction performances as assessed by Criterion B are also shown
by the correlations in Table 4 and the scatterplots in Fig. 3. While not
statistically significantly different, correlations of osmolality (both
methods), SG (both methods) and modified creatinine corrected AsIMM
against total As in drinking water were slightly stronger than for un-
corrected concentrations. Notably, conventional creatinine adjustment
resulted in a weaker correlation than all other, including uncorrected,
methods. The following performance ranking was observed relative to
Criterion B:
SG (conventional) Osmolality (conventional) Creatinine (modified)
SG (modified) Osmolality (modified)
Uncorrected Creatinine (conventional)
We note that, as can be seen in Fig. 1, there were large discrepancies
between the point estimates of z coefficients obtained when optimized
against either Criterion A or B. For Criterion A versus B: optima were
z=0.8 versus 0.49; 1.23 versus 0.72 and 1.2 versus 0.66 for creatinine,
SG and osmolality, respectively. Furthermore, for creatinine, improve-
ments for both criteria were achievable relative to conventional ad-
justment (z=1 - dashed line in Fig. 1), whereas optima for SG and
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Fig. 1. A graphical representation of the numerical derivation of the z coefficients used in the modified creatinine (A), SG (B) and osmolality (C) corrections. The
optimum z coefficients for Criterion A (i.e. corresponding to R=0 – lower yellow points) were selected. The 95% confidence intervals of Pearson correlations are
represented by the upper and lower lines running parallel to points. (For interpretation of the references to colour in this figure legend, the reader is referred to the
web version of this article.)
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osmolality were at either side of the dashed line, meaning optimization
for one Criterion came at the expense of the other. However, differences
in Pearson correlations for Criterion B were small between each op-
timum (e.g. R=0.65 for z=1.2 versus R=0.68 for z=0.66 for os-
molality correction) for all three correction methods and only small
strength increases in Criterion B correlations were achieved for large
differences in z. It is noted that the optimum Criterion A z coefficients
were remarkably similar between SG (z=1.23) and osmolality
(z=1.2); slightly more so than for Criterion B optima (0.72 versus
0.66).
4. Discussion
We have presented one of few investigations to comparatively assess
the performance of urinary dilution correction methods against mul-
tiple criteria, including a proposed modification of the mathematical
application of three commonly used corrections. Furthermore, this is
the first study to compare these methods against a performance cri-
terion based on external environmental exposure – As in drinking
water. We observed a substantial (> 30%) amount of variation among
uncorrected spot AsIMM concentrations attributable to dilution.
Correction methods had large and variable effects on urinary AsIMM
concentrations – capable of changing individual concentrations by a
factor of five. Conventional SG and osmolality corrections successfully
removed significant dilution variation from AsIMM concentrations,
whereas conventional creatinine over-corrected. It was possible to
completely remove dilution variation by modifying all three corrections
with z coefficients. Similarly, modified creatinine and both conven-
tional and modified applications of specific gravity and osmolality
generated stronger correlations of urinary AsIMM and drinking water As
concentrations than conventional creatinine, which gave weaker cor-
relations than uncorrected values. The performance of correction
methods relative to Criterion A was much more susceptible to im-
provement than Criterion B, relative to which only small differences
were observed between methods. Furthermore, creatinine correction
showed a much higher potential for modification than SG and osmol-
ality, highlighting the deficiency of creatinine correction in its con-
ventional form in comparison to the two alternative methods.
Our findings are consistent with others, namely our previous in-
vestigation (Middleton et al., 2016a), in which we demonstrated that
conventional creatinine correction did not perform as well as osmolality
in removing dilution variation from urinary lead, cadmium and AsIMM
concentrations. In the present study we went further an assessed a
proposed modification of creatinine, SG and osmolality correction
based on previously reported studies (Araki et al., 1990; Vij and Howell,
1998b; Sata and Araki, 1996; Sata et al., 1996) and demonstrated that
the efficacy of creatinine correction can be greatly enhanced by a
mathematical application which reflects underlying excretion me-
chanisms; accounting for the discordance between the slope of both
creatinine and the analyte being corrected in relation to UFR (Araki
et al., 1990). Furthermore the degree of discordance has been shown to
be specific to each analyte (Araki et al., 1986a). Our own study is just
one of many to address the limitations of creatinine correction, but
previous work has tended to focus on the implications of covariates on
creatinine excretion (Barr et al., 2005; Nermell et al., 2008b; Gamble
and Liu, 2005). We note that such covariates are also present for the
alternatives, such as osmolality and SG, now being turned to more
frequently (Yeh et al., 2015). For this reason, we recommend taking a
more objective approach to comparing and assessing the performance
of correction factors.
Our study was limited by a number of factors, including a modest
sample size, which likely prevented us from detecting significant dif-
ferences between many of our performance correlations. The age dis-
tribution of study participants, with a mean age of 62 and only 8 in-
dividuals under age 40, was also not representative of the wider
population and thus did not allow us to perform a systematic analysis of
the influence of demographic covariates on correction performance.
Our study group was from a rural population of private water supply
users (Middleton et al., 2016d), enabling us to assess correction per-
formance against a measure of external As exposure from drinking
water. Older participants were more available for participation during
daytime sampling visits.
A crude approach was used to derive the z coefficient used in
modified dilution corrections. Slopes of analyte concentrations against
UFR should be derived on single individuals at various hydration states
over time and likely vary by demographic and anthropometric factors
(Middleton et al., 2016a; Araki et al., 1986b). In the absence of a
comprehensive source of empirically derived slopes, a previously em-
ployed (Vij and Howell, 1998b) approach was considered a suitable
alternative to fulfil the aims of this paper and demonstrate proof of
concept. Using this approach, we selected (Fig. 1) z values which gave
the weakest correlations for corrected analyte concentrations and the
dilution metrics used to correct them (Criterion A). We based this se-
lection on the notion that the desired result of correction is to remove
dilution variation from the sample set. However, it is likely that a
forced correlation of absolute zero (Criterion A optimum) is not com-
pletely robust, which may have been evident in the disparity in optima
between both criteria. It is possible that the true optima lie somewhere
in the middle. Furthermore, the performance extremes for Criterion B
(R=0.62-R=0.68) were much more subtle than those for Criterion A
and a greater contrast in performance may have been evident if using a
more robust urinary exposure biomarker. For example, AsIMM in-
corporates a portion of DMA directly ingested and/or metabolised from
dietary As sources and hence not specific to drinking water. Further
studies using more specific biomarkers may highlight more obvious
Table 3
Geometric means (GM), geometric standard deviations (GSD) and ranges of
urinary AsIMM concentrations (μg/L except both creatinine methods - μg/g Cre)
corrected by different methods and GMs and ranges of the intra-individual
absolute percentage difference of urinary AsIMM concentrations corrected by
different methods, relative to uncorrected concentrations.
Correction method GM ± GSD (range)
urinary AsIMM
Absolute % difference
(range) relative to
uncorrected
Uncorrected 5.8 ± 2.3 (0.9–124)
Creatinine (conventional) 6.9 ± 2.0 (1.8–177) 39% (0.4–524%)
SG (conventional) 5.8 ± 2.0 (1.8–137) 23% (3–210%)
Osmolality (conventional) 5.8 ± 2.0 (1.6–122) 23% (0–183%)
Creatinine (modified) 6.7 ± 2.0 (1.8–164) 30% (0.3–333%)
SG (modified) 5.9 ± 2.0 (1.7–140) 29% (4–302%)
Osmolality (modified) 5.8 ± 2.0 (1.6–121) 27% (0–249%)
Table 2
Characteristics of the study group (n=202).
Demographic group n (%)
Male 106 (52)
Female 96 (48)
18–39 years old 8 (4)
40–49 years old 26 (13)
50–59 years old 41 (20)
60–69 years old 72 (36)
≥70 years old 55 (27)
Urinary analytes GM (range)
Creatinine (g/L) 0.83 (0.16–3.9)
SG 1.016 (1.005–1.031)
Osmolality (mOsm/kg) 520 (184–1161)
AsIMM (μg/L) 5.8 (0.9–124)
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Table 4
Pearson correlations for performance Criteria A and B across the range of correction methods investigated. Correlations share a letter (a, b and c) when not
significantly different from one another. *Uncorrected Criterion A correlations were almost identical for urinary AsIMM against each of urinary creatinine, osmolality
and specific gravity (see Fig. 2A–C).
Correction method Criterion A Criterion B
R (95% CI) Significance R (95% CI) Significance
Uncorrected⁎ 0.58 (0.48, 0.66) 0.65 (0.56, 0.72) ab
Creatinine (conventional) −0.17 (−0.30, −0.04) 0.62 (0.53, 0.70) ac
SG (conventional) 0.14 (−0.001, 0.27) a 0.68 (0.60, 0.75) b
Osmolality (conventional) 0.12 (−0.02, 0.25) a 0.67 (0.58, 0.74) bc
Creatinine (modified) 0.002 (−0.14, 0.14) b 0.66 (0.58, 0.73) b
SG (modified) 0.003 (−0.14, 0.14) b 0.66 (0.57 0.73) ab
Osmolality (modified) 0.002 (−0.14, 0.14) b 0.65 (0.56, 0.72) ab
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Fig. 2. Scatterplots of urinary AsIMM against dilution measurements (Criterion A) both pre- (A-C) and post- (D-I) correction by each method investigated. *** and *
denote statistical significance to< 0.001 and<0.05, respectively.
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performance differences between conventional and modified correction
methods. Despite these limitations, the study represents a valid proof of
concept with important implications to environmental exposure as-
sessment and the wider discipline of biomonitoring.
Our findings reiterate the widely recognised necessity of dilution
correction to remove the large amount of non-exposure relevant var-
iation from spot analyte concentrations. The effect of correction on
individual concentrations also supports this, but prompts caution re-
garding the interpretation of single spot concentrations. For example, in
relation to benchmark values such as biomonitoring equivalents (Hays
et al., 2010; Hays et al., 2014), and doping tests (Athanasiadou et al.,
2018). While spot samples are generally deemed acceptable for bio-
monitoring applications (Rivera-Núñez et al., 2010), 24 h or longer
term sampling regimes are frequently cited as the ideal preferred
sampling approach (Cornelis, 1996). However, in addition to being
inconvenient and having poor compliance, 24 h samples arguably still
require dilution correction if comparing between individuals with
highly variable daily water intakes. Therefore, the question of dilution
correction remains an important priority in advancing the practice of
urinary biomonitoring.
The utility of creatinine in dilution correction has looked bleak for
some time, but our results show that an appreciable degree of perfor-
mance can be enhanced by robust mathematical application – seldom
addressed to-date. However, creatinine's performance also depends on
its physiological robustness as a proxy of UFR, for which osmolality and
SG are superior. Nevertheless, this provides an opportunity for research
groups having already obtained data to apply this modified correction
method without the need for additional analyses. For example, for
studies in which urinary analyte and dilution (most likely creatinine)
data were collected, corrections can be re-applied using the modifica-
tions outlined in this paper to assess to what extent the findings differ to
those made when conventional correction was used. For some analytes,
this might be limited to a modest increase in the strength of association
between exposure and biomarker concentrations, but it is plausible, for
chemicals with very different excretion kinetics relative to dilution
markers, that greater influence will be observed. Readers wishing to
employ these methods can download R scripts made freely available in
our previous publication (Middleton et al., 2016a).
Further research in this area should address the derivation of cor-
rection coefficients (z values) by generating concentrations slopes for a
broad range of analytes against UFR for single individuals over varying
states of hydration. This should be conducted on a study group large
enough to facilitate analysis of demographic and anthropometric var-
iation. This will enable further optimisation of corrections and could be
tailored to specific analytes of interest and population subgroups. In
addition, a robust set of assessment criteria for the performance of di-
lution corrections should be developed, and may differ depending on
the intended purpose of the biomonitoring protocol, such as agreement
with internal dose measurements.
We have provided further evidence of the need to correct urinary
arsenic and other environmental chemical concentrations for dilution
variation and, in comparatively assessing a range of alternative
methods, concluding that conventional applications are likely sub-op-
timal as currently employed. Methods can be optimized with a more
robust mathematical application, with performance improvement par-
ticularly evident for creatinine. Further work is still needed to optimize
dilution correction methods with carefully selected criteria to validate
their performance and realize the full potential of urine biospecimens in
environmental health research and epidemiology.
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